T Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell Malignancies
Clinical trial NCT02659943 · COMPLETED
Trial details
- NCT number
- NCT02659943
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-21
- Primary completion
- 2018-06-12
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.